Top

Reactions Weekly

Published in:

01-12-2017 | Case report

Alemtuzumab

Anti-glomerular basement membrane antibody-positive glomerulonephritis complicated by secondary thrombotic microangiopathy and posterior reversible encephalopathy syndrome: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Yap SM, et al. Alemtuzumab-associated anti-glomerular basement membrane antibody-positive glomerulonephritis complicated by secondary thrombotic microangiopathy and posterior reversible encephalopathy syndrome. Multiple Sclerosis Journal 23 (Suppl. 1): 916-917 abstr. EP1740, No. 3, Oct 2017. Available from: URL: http://doi.org/10.1177/1352458517731285 [abstract] - Ireland

Title: Alemtuzumab
Anti-glomerular basement membrane antibody-positive glomerulonephritis complicated by secondary thrombotic microangiopathy and posterior reversible encephalopathy syndrome: case report
Publication date: 01-12-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39303-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Alemtuzumab

Anti-glomerular basement membrane antibody-positive glomerulonephritis complicated by secondary thrombotic microangiopathy and posterior reversible encephalopathy syndrome: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Crizotinib

Rivaroxaban withdrawal

Mycophenolate mofetil/prednisolone

Adalimumab

Celecoxib/hydroxychloroquine/sulfasalazine

Dexmedetomidine